Cargando…

New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489819/
https://www.ncbi.nlm.nih.gov/pubmed/26170615
http://dx.doi.org/10.2147/BTT.S87768
_version_ 1782379425227079680
collection PubMed
description
format Online
Article
Text
id pubmed-4489819
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-44898192015-07-13 New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum] Biologics Corrigendum Dove Medical Press 2015-06-29 /pmc/articles/PMC4489819/ /pubmed/26170615 http://dx.doi.org/10.2147/BTT.S87768 Text en © 2015 Frati et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Corrigendum
New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]
title New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]
title_full New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]
title_fullStr New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]
title_full_unstemmed New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]
title_short New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]
title_sort new product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [corrigendum]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489819/
https://www.ncbi.nlm.nih.gov/pubmed/26170615
http://dx.doi.org/10.2147/BTT.S87768